Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gregory Magee

Vascular Surgery Los Angeles, CA Medical Doctor

NPI 1841486222 CMS profile 870991

1520 San Pablo St Ste 4300, Los Angeles, CA 90033

Open in the dashboard

General payments

$151,547

223 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$11,640 paid to institutions, not to them · program year 2025

Through program year 2025, Gregory Magee of Los Angeles, CA is reported in the CMS Open Payments database as having received $151,547 across 223 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $11,640 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $49,492 40
2024 General $27,321 15
2023 General $21,551 27
2022 General $23,640 66
2021 General $7,294 27
2020 General $17,714 9
2019 General $4,533 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gregory Magee
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Gregory Magee were reported at $49,492. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Gregory Magee Vascular Surgery median Middle half National median
2019 $4,533 $796 $226–$2,363 $163
2020 $17,714 $348 $118–$1,110 $114
2021 $7,294 $471 $158–$1,421 $132
2022 $23,640 $725 $222–$2,183 $149
2023 $21,551 $836 $257–$2,440 $160
2024 $27,321 $909 $252–$2,619 $164
2025 $49,492 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $120,534 85 payments
  2. Silk Road Medical, Inc. $15,241 27 payments
  3. Cook Incorporated $3,273 3 payments
  4. Medtronic, Inc. $2,998 25 payments
  5. Penumbra, Inc. $2,280 11 payments
  6. Shockwave Medical, Inc $1,493 13 payments
  7. Cook Medical LLC $1,454 21 payments
  8. LeMaitre Vascular, Inc. $1,314 3 payments
  9. Bolton Medical Inc $674 7 payments
  10. NuVasive, Inc. $583 5 payments
  11. Other $1,702 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $96,650 24 payments
  2. Honoraria $20,575 4 payments
  3. Travel and Lodging $18,550 42 payments
  4. Food and Beverage $13,272 152 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,500 1 payment
Products named General payments · program years 2019–2025
  1. GORE TAG Thoracic Branch Endoprosthesis $46,942 12 payments
  2. GORE EXCLUDER Iliac Branch Endoprosthesis $40,256 11 payments
  3. EXCLUDER Conformable AAA Endoprosthesis with Active Control $34,859 18 payments
  4. GORE TAG Conformable Thoracic Stent Graft $33,786 10 payments
  5. C3 Delivery System $31,362 12 payments
  6. GORE EXCLUDER AAA Endoprosthesis $21,454 9 payments
  7. EXCLUDER Iliac Branch Endoprosthesis $17,227 4 payments
  8. ENROUTE Transcarotid Stent $15,105 26 payments
  9. ENROUTE Transcarotid Neuroprotection System $15,105 26 payments
  10. COOK $2,506 2 payments
  11. Other $17,806 158 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 100 billing codes

Paid by Medicare

$109,398

Medicare's payments for the services billed

Medicare patients

182

Average age 73

Services billed

473

64 women, 118 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 66%
Arthritis 60%
Diabetes 53%
Chronic kidney disease 47%
Heart failure 40%
COPD 36%
Atrial fibrillation 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

223 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record